KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.61 $7.24 Friday, 26th Apr 2024 AFMD stock ended at $5.03. This is 3.07% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.35% from a day low at $4.88 to a day high of $5.19.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Mar 21, 2024 $5.29 $5.49 $5.01 $5.04 73 529
Mar 20, 2024 $5.06 $5.33 $4.86 $5.29 105 001
Mar 19, 2024 $4.55 $5.14 $4.55 $5.10 106 871
Mar 18, 2024 $4.58 $5.04 $4.51 $4.54 100 286
Mar 15, 2024 $4.49 $4.70 $4.33 $4.57 75 028
Mar 14, 2024 $4.80 $4.86 $4.25 $4.40 241 983
Mar 13, 2024 $5.30 $5.37 $4.79 $4.79 182 277
Mar 12, 2024 $5.38 $5.95 $5.05 $5.29 196 266
Mar 11, 2024 $5.88 $6.74 $5.28 $5.38 201 349
Mar 08, 2024 $5.80 $6.10 $5.80 $6.08 60 412
Mar 07, 2024 $5.80 $6.29 $5.60 $5.82 71 527
Mar 06, 2024 $5.87 $6.12 $5.00 $5.70 289 257
Mar 05, 2024 $7.00 $7.20 $6.25 $6.69 44 324
Mar 04, 2024 $7.00 $7.20 $6.80 $6.90 146 761
Mar 01, 2024 $6.20 $6.96 $6.00 $6.70 133 053
Feb 29, 2024 $6.04 $6.40 $5.90 $6.02 122 189
Feb 28, 2024 $6.00 $6.04 $5.76 $5.90 57 187
Feb 27, 2024 $5.55 $5.95 $5.41 $5.88 79 759
Feb 26, 2024 $5.32 $5.70 $5.21 $5.60 47 866
Feb 23, 2024 $5.50 $5.50 $5.24 $5.32 46 871
Feb 22, 2024 $5.40 $5.60 $5.20 $5.33 68 766
Feb 21, 2024 $5.40 $5.52 $5.00 $5.26 56 154
Feb 20, 2024 $6.10 $6.10 $5.36 $5.51 99 804
Feb 16, 2024 $5.80 $6.03 $5.70 $6.03 47 295
Feb 15, 2024 $5.65 $6.00 $5.65 $5.80 59 050
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT